DiaMedica Therapeutics Inc. (NASDAQ: DMAC)
$3.48
-0.1000 ( -2.79% ) 22.1K
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Market Data
Open
$3.48
Previous close
$3.58
Volume
22.1K
Market cap
$144.90M
Day range
$3.32 - $3.58
52 week range
$1.94 - $4.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 64 | Nov 13, 2023 |
8-k | 8K-related | 22 | Nov 13, 2023 |
8-k | 8K-related | 15 | Sep 05, 2023 |
8-k | 8K-related | 15 | Aug 14, 2023 |
10-q | Quarterly Reports | 64 | Aug 14, 2023 |